PubMed HealthSearch

PubMed · 6341726

[Primary acute hyperparathyroidism].

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

T Lucas Morante, A Felip Hosselbarth, J Morató Griera, J M Gómez Sáez, A Martín Zurro, J Soler Ramón, A Sitges Serra. 1983-01-29. [Primary acute hyperparathyroidism].. https://pubmed.ncbi.nlm.nih.gov/6341726/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Thrombolytic therapy with streptokinase in acute ischemic stroke.

BACKGROUND: In patients with acute ischemic stroke, early treatment with thrombolytic agents is thought to permit reperfusion of ischemic neurons and to promote recovery of function. The Multicenter Acute Stroke Trial-Europe (MAST-E) was designed to assess the efficacy and safety of streptokinase in patients with acute ischemic stroke. METHODS: Patients with moderate-to-severe ischemia in the territory of the middle cerebral artery were randomly assigned to receive streptokinase (1.5 million units over a period of one hour) or placebo within six hours after the onset of stroke. The primary efficacy outcome was a binary criterion combining mortality and severe disability at six months, with severe disability defined as a score of 3 or higher on the Rankin scale. The primary safety outcomes were mortality at 10 days and cerebral hemorrhage. RESULTS: All randomized patients (156 in the streptokinase group and 154 in the placebo group) were evaluated at six months. The incidence of the primary efficacy outcome was similar in the two groups (124 patients in the streptokinase group and 126 in the placebo group died or had a Rankin score > or = 3). However, the mortality rate at 10 days was significantly higher in the streptokinase group than in the placebo group (34.0 percent vs. 18.2 percent, P = 0.002). The higher rate in the streptokinase group was mainly due to the hemorrhagic transformation of ischemic cerebral infarcts. At six months, more deaths had occurred in the streptokinase group than in the placebo group (73 vs. 59, P = 0.06). CONCLUSIONS: In patients with acute ischemic stroke, treatment with streptokinase resulted in an increase in mortality. The routine use of streptokinase cannot be recommended in acute ischemic stroke.

Acute Disease

Nitric oxide production during the hyperacute vascular rejection.

A complete understanding of the biological mechanisms that take part in the hyperacute vascular rejection is necessary to prevent its development. Nitric Oxide (NO) release by the graft could be one of those mechanisms as cytokine induction of NO synthase in reticuloendothelial cells produces NO with cytotoxic activity. We have performed 20 heterotopic pig-to-dog kidney xenotransplantations in order to determine if cytotoxic NO is released during the hyperacute rejection. Nitrites and cGMP levels were determined in plasma samples taken from the graft artery and vein until vessel thromboses. NO synthase activity was measured in pieces from renal artery and renal tissue. The results show that after discordant xenotransplantation, inducible NO synthase is activated in the transplanted organ, indicating that NO can mediate host tissue damage during the hyperacute rejection.

Acute Disease

A new animal model of reversible acute pancreatitis.

Numerous animal models of acute pancreatitis are utilized to assess pathophysiologic events and to evaluate therapeutic options. However, none of the small animal models simulates reversible biliary pancreatitis with long-term follow-up (weeks). The present study was designed to create a reversible model of acute biliary pancreatitis in small experimental animals. Male Sprague-Dawley rats were subjected to laparotomy, and the common bile duct was dissected free at its junction to the duodenum. Experimental animals had a polypropylene tie occluder passed around the common bile duct and brought out through a separate stab wound in the abdominal wall. The duct was occluded for 24 hr; the blockage was then relieved and the tie withdrawn from the animal. Sham-operative animals had similar surgical procedures but without the occluder. Serum amylase values on Days 1 and 2 following surgery were significantly increased in the experimental group, but were not different from those of control animals on Day 3 or 4, suggesting reversibility of this biliary pancreatitis model. Likewise, serum bilirubin levels were increased in the experimental group on Days 1 and 2. Histologic analysis revealed edema, zymogen degranulation, inflammatory infiltration, vacuolization of acinar cells, and focal areas of fat and parenchymal necrosis in the experimental group. Only mild edema was observed in the sham-operative controls due to surgical manipulation. Pancreatic tissues obtained at 1 week postinduction of pancreatitis showed near total destruction of the architecture and dissolution of zymogen granules; in contrast, histology at the 3rd week showed almost normal-appearing pancreas with return of zymogen granules, suggesting recovery from the acute pancreatitis. This reproducible and reversible model of acute pancreatitis in the rat will provide for further studies in the pathogenesis of pancreatitis and its therapeutic interventions.

Acute Disease